We are a specialty pharmaceutical
company focused on the development and
commercialization of innovative therapies for the
treatment of development in Auto-immune Disease,
Multiple Sclerosis, Rheumatoid Arthritis,
Alzheimer Disease, and Duchene Muscular Dystrophy.
InnoBioscience is uniquely positioned to develop a
portfolio of its own products to treat patients with
these unmet medical needs. Developing strategic
alliances and partnerships is an integral part of
our corporate strategy. InnoBioscience is committed
to collaborating with strategic partners with a
shared passion for realizing the significant
potential of future research and development for
disease areas with high unmet medical need.
If you would like more information about building a
partnership with InnoBioscience please leave your
contact information below.